ClinicalTrials.gov
public full text
Public Domain
Cytoflavin in Combination With Reperfusion in Stroke Patients
Evaluation of the efficacy and safety of Cytoflavin®, solution for intravenous administration, (OOO NTFF POLYSAN, Russia) for 10 days, patients with cerebral infarction who receive reperfusion therapy, with the start of treatment within the first 24 hours from the stroke onset, compared to treament with any other neuroprotective drug which may be used in routine clinical practice.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA#902634
- A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults#1007964
- Stroke Thrombectomy and Aneurysm Registry#850989
- Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion#1462317
- Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study#1295802
Record · ID 1477463
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive